Organon & Co.

NYSE:OGN

14.96 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 1,5921,5821,6071,6221,5981,5191,6081,5381,4851,5371,5851,5671,6041,6001,5951,5063,1771,6131,5261,780
Cost of Revenue 6966596686656836126405805945515885615996095835911,814535460538
Gross Profit 8969239399579159079689588919869971,0061,0059911,0129151,3631,0781,0661,242
Gross Profit Ratio 0.5630.5830.5840.590.5730.5970.6020.6230.60.6420.6290.6420.6270.6190.6340.6080.4290.6680.6990.698
Reseach & Development Expenses 130111116112134137128129142127106961891117667154545145
General & Administrative Expenses 0000260000215000245000546000
Selling & Marketing Expenses 0000209000255000236000198000
SG&A 470422437431469538451435470440423371481388416382744321284317
Other Expenses 2960-6-3-4-4-1-60-414-97-99-102-82-2-37811-11
Operating Expenses 896533553543603675579564612567529467670499492449898375335362
Operating Income 03903864143120.2320.389331227358432486334394458466465703731880
Operating Income Ratio 00.2470.240.2550.195000.2150.1530.2330.2730.310.2080.2460.2870.3090.1460.4360.4790.494
Total Other Income Expenses Net 129-183-151-178-208-152-135-159-168-137-181-97-98-128-211-12-22-29-36
Income Before Tax 12920723523610480254235111282287442236389437467453681702844
Income Before Tax Ratio 0.0810.1310.1460.1450.0650.0530.1580.1530.0750.1830.1810.2820.1470.2430.2740.310.1430.4220.460.474
Income Tax Expense 20-1524035-44222125835553943466672173121116110
Net Income 10935919520154658242177108227234348202323427399368547542703
Net Income Ratio 0.0680.2270.1210.1240.3420.0380.150.1150.0730.1480.1480.2220.1260.2020.2680.2650.1160.3390.3550.395
EPS 0.421.390.760.792.140.230.950.70.420.890.921.370.81.271.681.581.452.162.142.78
EPS Diluted 0.421.380.750.782.130.230.950.690.420.890.921.360.791.271.681.581.452.162.142.78
EBITDA 338402432479374293447451279476518592396569563504509743765938
EBITDA Ratio 0.2120.2540.2810.2950.2320.150.2410.2520.1880.270.3040.3440.2090.3080.3270.3330.1820.4660.5090.527